Skip to main content

Table 2 Crude and adjusted longitudinal estimates of the odds of plasma HIV-1 RNA viral load non-suppression among 657 ART-exposed active PWID, Vancouver, 1996 – 2012

From: Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis

Characteristic

OR1

95% CI2

p-value

AOR3

95% CI

p-value

Incarceration4

      

 Yes vs. no

2.00

1.47 – 2.72

< 0.001

1.54

1.10, 2.16

0.011

Age

      

 Per year

0.90

0.87 – 0.92

< 0.001

0.91

0.88, 0.94

< 0.001

Gender

      

 Female vs. male

1.69

1.07 – 2.67

0.024

   

Aboriginal ancestry

      

 Yes vs. no

1.35

0.86 – 2.11

0.189

   

Homeless5

      

 Yes vs. no

2.38

1.59 – 3.58

< 0.001

1.83

1.19, 2.82

0.006

Education

      

 ≥HS vs < HS

0.89

0.66 – 1.22

0.476

   

Employment4

      

 Yes vs. no

0.48

0.25 – 0.92

0.028

   

Heroin injection4

      

 ≥ Daily vs. < daily

2.76

2.07 – 3.69

< 0.001

2.09

1.53, 2.87

<0.001

Cocaine injection4

      

 ≥ Daily vs. < daily

1.52

1.18 – 1.97

0.001

   

Crack cocaine use4

      

 ≥ Daily vs. < daily

1.37

1.06 – 1.76

0.015

   

Binge drug use4

      

 Yes vs. no

1.09

0.88 – 1.36

0.426

   

MMT5

      

 Yes vs. no

0.46

0.35 – 0.59

< 0.001

0.52

0.39, 0.70

< 0.001

Sex work4

      

 Yes vs. no

2.21

1.47 – 3.33

< 0.001

   

HIV MD experience

      

 < 6 patients vs. ≥ 6

1.93

1.08 – 3.46

0.026

   

PI in first ART regimen

      

 Yes vs. no

1.06

0.68 – 1.67

0.794

   

CD4+ cell count4

      

 Per 100 cells/mL

0.48

0.44 – 0.53

< 0.001

0.51

0.47, 0.56

< 0.001

ART adherence4

      

 ≥ 95% vs < 95%

0.03

0.02 – 0.04

< 0.001

   
  1. 1Odds Ratio; 295% Confidence Interval; 3Adjusted Odds Ratio; 4Refers to the six month period prior to follow-up; 5Refers to current status.